Bioventus
BVS
BVS
138 hedge funds and large institutions have $537M invested in Bioventus in 2024 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
8.48% more ownership
Funds ownership: 60.46% → 68.94% (+8.5%)
11% less call options, than puts
Call options by funds: $2.32M | Put options by funds: $2.6M
Holders
138
Holding in Top 10
4
Calls
$2.32M
Puts
$2.6M
Top Buyers
| 1 | +$10M | |
| 2 | +$8.34M | |
| 3 | +$6.36M | |
| 4 |
OAM
Ophir Asset Management
Sydney,
Australia
|
+$6.26M |
| 5 |
Morgan Stanley
New York
|
+$5.79M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$3.27M | |
| 3 | -$1.8M | |
| 4 |
Millennium Management
New York
|
-$1.42M |
| 5 |
Renaissance Technologies
New York
|
-$1.38M |